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A B S T R A C T
Aims: We studied the association between fear of hypoglycaemia (FoH) and various diabetes self-
management practices.
Methods: Data from 798 individuals with type 1 diabetes participating in the FinnDiane Study were in-
cluded. Self-reported questionnaires were used to assess FoH and self-management practices (e.g. dietary
intake, insulin administration, physical activity). For glycaemic control, we used both the latest HbA1c
measurements and the serial HbA1c measurements from the medical ﬁles. Factor analysis was used to
reveal underlying constructs within the food frequency section of the diet questionnaire.
Results: In all, 44% and 63% of men and women reported FoH, respectively. In men, FoH was associated
with higher mean serial HbA1c levels, higher number of reported self-monitoring of blood glucose (SMBG),
higher carbohydrate intake, and lower scores in the “high-fat” factor. In women, FoH was associated with
a higher number of reported SMBGs and higher energy intake. No difference was observed in physical
activity and insulin administration.
Conclusions: FoH has various implications for the self-management of diabetes. More studies are however
needed to assess on one hand the association between FoH and diabetes self-management, and on the
other hand, FoH and its long term consequences, such as the emergence of diabetic complications and
mortality.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Good glycaemic control is a prerequisite for reducing the risk of
late complications in type 1 diabetes. Normalising blood glucose is,
however, challenging due to the potential risk of hypoglycaemia.
Hypoglycaemia is, indeed, a common adverse event associatedwith
insulin treatment [1], and a three-fold increase in the occurrence
of hypoglycaemic episodes, with intensifying insulinmanagement,
was observed in the Diabetes Control and Complications Trial [2].
Hypoglycaemias are categorised as “mild” and “severe” based on
the individual’s ability to self-treat oneself. During severe epi-
sodes, external assistance is required for recovery. Estimates of the
frequencies of hypoglycaemias vary depending on the level of
hypoglycaemia and the population in question. Roughly, two epi-
sodes of mild hypoglycaemias per week, have been reported in type
1 diabetes [3], and in a population-based study, 82% of individuals
with type 1 diabetes reported having experienced at least one
hypoglycaemic event over the course of onemonth [1]. With regards
to the severe hypoglycaemias, an overall rate of 1.3 episodes per
patient-year was observed in an unselected population of individu-
als with type 1 diabetes [4]. However, with increasing disease
duration, the frequency of episodes seems to increase, as over 3 epi-
sodes per patient-year were observed among individuals with
diabetes duration over 15 years [5].
The symptoms of hypoglycaemia, such as shaking, impaired
vision, anxiousness and sweating may be inconvenient and un-
pleasant. It is, however, the life threatening nature of the severe
hypoglycaemias, which are particularly worrisome to many indi-
viduals with insulin-treated diabetes. Fear of hypoglycaemia (FoH)
appears to be common [6]. Amongst others, factors such as trait
anxiety and frequency of experienced severe hypoglycaemic epi-
sodes have been associated with FoH [7,8].
There are various self-management strategies that individuals
with FoH use to cope with their fear. One may, for example, ad-
minister less insulin than required [9] or restrain from physical
activity [10]. Alternatively, one could increase the amount of food
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eaten or eat more carbohydrate-rich food stuffs in order to avoid
hypoglycaemia [11]. Despite these actions that all aim at keeping
the blood glucose concentrations at higher levels, there does not
seem to be a clear association between FoH and HbA1c [8,12–14].
The aim of the current study was to evaluate the association
between self-reported FoH and various diabetes self-management
practices, including self-monitoring of blood glucose (SMBG), food
intake, and leisure-time physical activity (LTPA), in a large and well
characterised population of patients with type 1 diabetes. More-
over, the association between FoH and HbA1c was studied.
Methods
Study subjects
Study subjects were participants in the Finnish Diabetic Ne-
phropathy (FinnDiane) Study. From this study of people with type
1 diabetes, we included all who had ﬁlled in both the diabetes ques-
tionnaire and the diet questionnaire. Thus, for the current cross-
sectional analyses, we included data from a total of 798 individuals.
The Ethics Committee of the Hospital District of Helsinki and
Uusimaa approved the study protocol. Signed informed consent was
obtained from all participants prior to study inclusion.
Clinical methods
During the study visits, participants’ height andweight weremea-
sured in light clothing. Based on these measurements, body mass
index was calculated. Following a 10-minute rest, blood pressure
was measured in the sitting position. The measurement was re-
peated with a minimum of 2 minutes’ interval, and the mean of the
two measurements were used in the analyses. Blood samples were
collected and HbA1c was determined locally by standardised assays.
In addition, data on all HbA1c measurements conducted at the par-
ticipating centres were collected from the patients’ medical ﬁles.
The serial HbA1c data collected from these medical ﬁles and from
the measurements conducted at the study visits (on average
26.6 ± 16.9 measurements per patient) were used to calculate the
mean serial HbA1c and the coeﬃcient of variation for these HbA1c
values. The coeﬃcient of variation was considered a measure of
HbA1c variability. Only those participants with a minimum of three
HbA1c measurements were included in the analyses of HbA1c vari-
ability (n = 733). Serum lipid and lipoprotein concentrations were
measured as previously described [15]. The daily insulin dose was
self-reported. Based on these reports and the measured weight,
insulin dose per body weight (IU/kg) was calculated.
Urinary albumin excretion rate (AER) in at least two out of three
timed 24-hour or overnight urine collections was used to assess
participants’ renal status. The following classiﬁcations were made:
normal albumin excretion rate (AER <20 μg/min or <30 mg/24 h),
microalbuminuria (AER ≥20 and <200 μg/min or ≥30 and
<300 mg/24 h), macroalbuminuria (AER ≥200 μg/min or ≥300 mg/
24 h), and end-stage renal disease (ESRD) (in dialysis or with kidney
transplant). Diabetic nephropathy was deﬁned as macroalbuminuria
or ESRD. Retinal laser-treatment (data obtained from the medical
records) was used as an indication of severe retinopathy. Data on
smoking and social class (grouped as unskilled/skilled blue-collar,
lower/upper white-collar, farmers, and others) were self-reported.
Unskilled blue-collar workers were classiﬁed as having a low so-
cioeconomic status (SES).
Questionnaires
The diabetes questionnaire was used to collect data on various
diabetes speciﬁc issues of clinical importance. The diabetes ques-
tionnaire is a self-reported structured form, designed to collect data
on patients’ perceptions of their disease. The questionnairewas de-
signed by a panel of experienced diabetes specialists. Based on years
of clinical work, these specialists aimed at formulating a question-
naire that would shed light on the patients’ subjective view of their
disease. Thus, by design, the questionnaire is subjective in nature.
Two questions from this questionnaire were used to approximate
FoH: 1. Are you afraid of hypoglycaemia?2.Has fear of hypoglycaemia
led you to eat just in case. FoH was assumed if a positive reply was
given to both of these questions.
Dietary intake was measured by two separate methods, as pre-
viously described [16]. In short, participants (n = 798) ﬁlled in a diet
questionnaire that was designed to capture information on their ha-
bitual dietary intake. As part of this diet questionnaire, a 19-item
food frequency questionnaire (FFQ) was also completed. In this FFQ,
the frequency of consuming themost common food items in Finland
were queried. Thus, participants reported the frequency of con-
suming ﬁsh dishes, meat dishes, poultry, sausages and cold cuts, eggs,
legumes, fresh vegetables, cooked vegetables, potatoes, pasta and
rice, fruits and berries, high-fat cheese, low-fat cheese, yoghurt, ice
cream, soft drinks, pastries, sweets, and fried and grilled foods using
a seven scale responses. Upon returning the diet questionnaire, pa-
tients were allocated a 3-day exercise and food record (twoweekdays
and one weekend day). In this record, data on food consumption,
physical activity, insulin use, and SMBG were reported. In order to
capture some seasonal variation in the dietary intake, the 3-day re-
cording was repeated in 2–3 months. In the current analyses,
individuals who ﬁlled in the record for a minimum of three days
(n = 615) were included. AivoDiet software (version 2.0.0.1, AIVO,
Turku, Finland), based on the Finnish National Food Composition
Database (Fineli) [17], was used to calculate the mean daily energy
and nutrient intakes reported in the records.
From the same record, the number of reported blood glucose
measurements per journal day, the mean value of the reported
blood glucose measurements, and the number of days with re-
ported blood glucose values <3.5 mmol/l (cut off level previously
used by Leese et al. [18]) per journal day were calculated. Addi-
tionally, the mean reported insulin dose divided by body weight
was calculated. Finally, we calculated the daily metabolic equiva-
lent of task hour (METh), which reﬂects the energy cost of LTPA.
The METh was calculated by multiplying the duration of the activ-
ity, reported in the record, by the activity- and intensity-speciﬁc
metabolic equivalent.
Statistical analyses
Descriptive statistics are reported as percentages for categori-
cal data, median (interquartile range) for non-normally distributed
continuous data, and mean ± standard deviation (SD) for normally
distributed continuous data. The respective group comparisons were
performed with chi-squared test, Mann–Whitney U-test, and
independent-sample t-test. Exploratory factor analysis (maximal like-
lihood and varimax rotation) was conducted to reveal underlying
constructs within the FFQ of the diet questionnaire. In the analy-
sis, the number of factors identiﬁed was based on eigenvalues >1.0,
and items with factor loading | ≥ 0.20| with a particular factor, were
included. The factor score was the sum of the scores for all items
associated with that particular factor multiplied by its correspond-
ing factor loading. The obtained scores were used as dependent
variables in the analyses. Forward stepwise logistic regression anal-
yses were used to assess factors independently associated with FoH.
For the model, all items that were statistically signiﬁcant (p < 0.05)
or borderline signiﬁcant (p < 0.08) in the bivariate analyses were in-
cluded. All data were analysed using IBM SPSS Statistics forWindows,
Version 22.0 (IBM Corp, Armonk, NY, USA).
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Results
Of the 798 participants, 492 (61.7%) were self-reportedly afraid
of hypoglycaemias (question 1), and 566 (70.9%) reported eating “just
in case” because of their fear of hypoglycaemias (question 2). A total
of 437 (55%) individuals replied positively to both of these ques-
tions and were thus categorised as having FoH. As women reported
FoH more frequently than men (63% vs. 44%, Table 1), we decided
to conduct separate analyses for men and women. In men, with and
without FoH, serial HbA1c measurements were based on 25.1 ± 17.4
and 23.9 ± 14.4 individual measurements (p = 0.896). The respec-
tive ﬁgures for women were 28.0 ± 17.7 and 28.9 ± 17.6 (p = 0.637).
There was a tendency for men with FoH to be younger than men
without FoH (p = 0.054, Table 1). No other differences in the back-
ground data between the FoH groups were observed. In men, the
mean serial HbA1c level was modestly higher amongst those with
FoH. No differences were observed between the FoH groups in the
amount of daily insulin dose per body weight, the frequency of
insulin pump use, the latest HbA1c values, and the HbA1c variabil-
ity of the serial measurements.
A total of 252men and 363 women ﬁlled in the exercise and food
record (Table 2). FoH was observed in 108 (43%) and 225 (62%) of
these respective participants. Compared to those without FoH, both
men and women with FoH reported more frequent SMBG. These
Table 1
Patient characteristics divided by gender and fear of hypoglycaemia status
Men Women
FoH, yes
n = 154 (43.9%)
FoH, no
n = 197 (56.1%)
p FoH, yes
n = 283 (63.3%)
FoH, no
n = 164 (36.7%)
p
Background data
Age, years 48.6 ± 13.3 51.4 ± 13.0 0.054 47.2 ± 13.6 48.4 ± 12.2 0.347
Diabetes duration, years 30.8 ± 14.1 31.0 ± 13.2 0.890 31.2 ± 13.3 30.9 ± 13.4 0.832
Current smoking, % 14.9 14.4 0.999 12.0 11.9 <0.999
Low SES, % 14.6 14.7 0.999 9.9 14.6 0.228
Retinopathy, % 43.4 47.4 0.514 36.2 34.6 0.758
Diabetic nephropathy, % 26.7 29.4 0.767 13.4 12.8 0.999
BMI, kg/m2 26 (23–28) 26 (24–28) 0.814 24 (22–28) 25 (23–28) 0.339
Total cholesterol, mmol/l 4.2 (3.8–4.8) 4.4 (3.9–5.1) 0.224 4.5 (4.0–5.2) 4.7 (4.3–5.2) 0.166
HDL cholesterol, mmol/l 1.4 (1.2–1.6) 1.4 (1.1–1.6) 0.683 1.7 (1.4–2.0) 1.8 (1.5–2.2) 0.080
Triglycerides, mmol/l 1.1 (0.8–1.4) 1.1 (0.8–1.5) 0.675 0.9 (0.6–1.2) 0.9 (0.7–1.1) 0.910
Systolic blood pressure, mmHg 141 (132–153) 142 (133–155) 0.382 134 (122–148) 132 (120–146) 0.454
Diastolic blood pressure, mmHg 79 ± 11 80 ± 9 0.321 77 ± 10 76 ± 9 0.473
Insulin and HbA1c data
Insulin dose, IU/kg 0.58 (0.46–0.73) 0.61 (0.48–0.76) 0.223 0.53 (0.44–0.69) 0.56 (0.45–0.75) 0.557
Insulin pump, % 7.5 10.4 0.510 17.4 12.9 0.300
Latest HbA1c, % 8.1 (7.4–8.6) 8.0 (7.2–8.8) 0.827 8.2 (7.5–9.1) 8.1 (7.2–9.0) 0.489
HbA1c, mmol/mol 65 (57–71) 64 (55–73) 66.1 (59–76) 65 (55–75)
Mean* HbA1c, % 8.3 (7.6–9.1) 8.0 (7.4–8.9) 0.015 8.3 (7.6–9.0) 8.3 (7.4–9.1) 0.934
HbA1c, mmol/mol 67 (60–76) 64 (57–74) 67 (60–75) 67 (57–76)
Coeﬃcient of variation for HbA1c* 7.8 (5.8–11.0) 7.7 (5.9–11.0) 0.546 8.1 (6.1–11.4) 8.2 (6.6–10.6) 0.717
Data are presented as median (interquartile range) for continuous non-normally distributed variables, mean ± SD for continuous normally distributed variables, and fre-
quency (%) for categorical variables. FoH, fear of hypoglycaemia; Low SES, low socioeconomic status (unskilled blue collar workers); IU, international units. *Calculated from
the serial HbA1c measurements.
Table 2
Blood glucose monitoring, leisure-time physical activity, and dietary intake in the groups divided by gender and fear of hypoglycaemia status
Men Women
FoH, yes
n = 108 (42.9%)
FoH, no
n = 144 (57.1%)
p FoH, yes
n = 225 (62.0%)
FoH, no
n = 138 (38.0%)
p
Reported SMBG/day, n 3.6 ± 1.8 3.2 ± 1.8 0.063 3.9 ± 1.9 3.5 ± 1.7 0.025
Hypoglycaemia* measurements per number of journal days, n 0.2 (0.0–0.5) 0.2 (0.0–0.5) 0.372 0.3 (0.0–0.5) 0.2 (0.0–0.5) 0.538
Mean of reported BG values, mmol/l 8.1 (7.1–9.5) 7.6 (6.5–8.9) 0.041 8.2 (7.0–9.4) 7.8 (6.8–9.7) 0.485
METh per number of journal days 4.3 (2.5–8.4) 5.0 (2.4–8.6) 0.901 5.3 (3.2–8.3) 4.5 (2.7–8.0) 0.242
Dietary intake
Energy, MJ 8.8 ± 2.5 8.3 ± 2.4 0.118 7.1 (6.1–8.1) 6.7 (5.8–7.7) 0.059
Carbohydrate, E% 43.9 ± 6.5 43.4 ± 7.5 0.568 44.9 ± 6.4 44.0 ± 7.8 0.221
Carbohydrate, g 233 (172–282) 208 (160–256) 0.068 188 (155–226) 174 (146–216) 0.065
Fat, E% 35.2 (30.9–39.0) 36.4 (30.3–39.9) 0.372 34.8 ± 6.1 35.3 ± 6.5 0.545
Fat, g 77 (61–101) 75 (60–97) 0.360 65 ± 21 67 ± 22 0.244
Protein, E% 16.3 (14.8–18.7) 16.7 (15.0–18.3) 0.728 16.2 (14.3–18.5) 17.2 (15.0–18.9) 0.024
Protein, g 83 (68–102) 79 (64–100) 0.175 69 (60–81) 68 (59–79) 0.475
Protein, g/kg 1.11 ± 0.33 0.96 ± 0.26 0.001 1.05 (0.84–1.26) 0.98 (0.82–1.16) 0.071
Alcohol, E% 0.96 (0–2.70) 1.18 (0–3.94) 0.880 0.53 (0–2.99) 0.05 (0–2.54) 0.360
Alcohol, g 2.56 (0–8.75) 3.59 (0–9.99) 0.700 1.52 (0–7.28) 0.12 (0–5.85) 0.365
Sucrose, g 34.0 (22.2–54.5) 24.8 (16.2–41.0) 0.169 32.0 (20.6–45.0) 28.5 (17.6–45.3) 0.100
Fibre, g 23.2 (17.6–30.2) 21.6 (16.1–26.2) 0.192 22.4 (17.3–28.3) 20.9 (16.9–25.5) 0.209
Data are presented as median (interquartile range) for continuous non-normally distributed variables, and mean ± SD for continuous normally distributed variables. FoH,
fear of hypoglycaemia; SMBG, self-monitoring of blood glucose; BG, blood glucose; MET, metabolic equivalent of task; E%, percentage of total energy intake. *Blood glucose
values below 3.5 mmol/l.
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modest differences were, however, signiﬁcant only among women.
In men, the mean of the blood glucose values, reported in the jour-
nals, was higher amongst individuals with FoH. No differences were
observed in the numbers of reported hypoglycaemic blood glucose
values and levels of reported LTPA during the journal days. There
was a tendency, for bothmen (p = 0.068) andwomen (p = 0.065) with
FoH, to eat more carbohydrates (g/day) compared to those without
FoH. Moreover, men with FoH consumed more protein per body
weight than those without FoH, while women with FoH obtained
lower proportion of energy from proteins. Women with FoH also
tended to consumemore energy than those without FoH (p = 0.059).
Seven factors with a high degree of inter-correlation were formed
from the FFQ (Table 3). Based on their contents, these clusters were
named “vegetable”, “sweet”, “snack”, “modern”, “traditional”, “ﬁsh”,
and “high-fat”. In the bivariate analyses, men with FoH were ob-
served to score lower in the “high-fat” factor, and women with FoH
scored higher in the “sweet” factor (Table 4).
Age, mean serial HbA1c level, the number of reported daily SMBGs,
and the mean of reported blood glucose values in the journals were
entered in the logistic regression model. Additionally, of the dietary
variables, energy intake, carbohydrate intake (g/day), protein intake
(g/kg), and factors “sweet”, “snack”, and “high-fat” were also in-
cluded. In men, higher mean values of serial HbA1c measurements,
higher number of reported daily SMBGs, higher carbohydrate intake
and lower scores in the “high-fat” factor were all independently as-
sociated with FoH (Table 5). In women, higher energy and
carbohydrate intakes were independently associated with FoH.
Discussion
Besides the psychological distress associated with fear, the sig-
niﬁcance of FoH is frequently related to the actions taken to keep
the blood glucose at a “safely high” level. Indeed, in the current study,
we observed that in men, FoH was independently associated with
higher mean serial HbA1c level and higher carbohydrate intakes. Ad-
ditionally, both men and women with FoH were observed to more
frequently monitor their blood glucose levels.
The association between FoH and glycaemic control is not fully
established, and lack of such association has been reported in a
number of studies [8,11–13,19]. In concordance with these studies,
we observed that the latest HbA1c measurement was no different
between the two groups. Opposite observations have, however, also
been made as Anderbro et al. reported that the aloneness subscale
of the Hypoglycaemia Fear Survey was related to higher HbA1c levels
[14]. Moreover, individual cases are known to exist where FoH has
deleterious effect on glycaemia [20]. Based on the mixed results ob-
tained on this subject, it is likely that the association between FoH
and glycaemic control is complex and more studies are needed to
adequately reveal issues related to it.
No differences were observed in the levels of reported physical
activity by the FoH status. FoH has, previously, been identiﬁed as
a major barrier to regular physical activity in type 1 diabetes [10].
One explanation to the observed difference could be the method
used to assess physical activity. While in our study, participants were
instructed to report the actual physical activity during the record-
keeping days, Brazeau et al, in their study, queried how likely it would
be that FoH would keep the respondents from engaging in physi-
cal activity over a particular period of time [10]. Given the frequency
of iatrogenic hypoglycaemias, in this patient population, it is likely
that most individuals would agree restraining from physical activ-
ity when facing a risk of low blood glucose level. This does not mean,
however, that the actual amount of physical activity would auto-
matically be lower. It should also be noted that the frequencies of
reported hypoglycaemias during the record-keeping days, in the
current study, were low and did not differ by the FoH status. This
could further explain why the levels of physical activity were not
different between the groups. On the other hand, should FoH un-
conditionally reduce the level of overall physical activity, the reason
it was not observed in the current study could be due to the
limitations related to the questionnaire used. Given the high per-
centage of FoH observed, it is possible that also individuals with
minor concerns related to hypoglycaemias, and not only those with
actual “fear”, were also included in the populationwith “FoH”. Should
this have taken place, it would most likely have diluted, not only
the results related to physical activity, but also to other self-
management practices.
Of the dietary variables, higher carbohydrate intake and lower
scores in the “high fat” factor were, in men, associated with FoH,
while women with FoH reported somewhat higher energy intakes.
In the bivariate analyses, also women with FoH tended to show
higher carbohydrate intakes. Comparing our results with previous
research is diﬃcult, as the association between FoH and dietary
Table 3
Formed factors in the factor analysis
Factor Included items from the food
frequency questionnaire
Eigenvalue % of variance
Vegetable Cooked vegetables, legumes, fresh
vegetables
2.16 11.3
Sweet Sweets and chocolate, sweet
pastry, ice cream, soft drinks
1.86 9.8
Snack Fruits and berries, yoghurt and
curd, fresh vegetables, low-fat
cheese
1.56 8.2
Modern Pasta and rice, poultry, meat
dishes, fried and grilled foods
1.33 7.0
Traditional Meat dishes, potatoes, and
sausages and cold cuts
1.32 7.0
Fish Fish dishes 1.07 5.6
High-fat High-fat cheese, eggs, and low in
low-fat cheese
1.03 5.4
Table 4
Dietary factor scores in the groups divided by gender and fear of hypoglycaemia
Men Women
FoH, yes
n = 154 (43.9%)
FoH, no
n = 197 (56.1%)
p FoH, yes
n = 283 (63.3%)
FoH, no
n = 164 (36.7%)
p
Vegetable −0.30 (−0.69–0.25) −0.26 (−0.71–0.39) 0.736 −0.15 (−0.65–0.68) −0.07 (−0.54–0.68) 0.374
Sweet −0.21 (−0.54–0.31) −0.26 (−0.60–0.27) 0.220 −0.06 (−0.51–0.50) −0.26 (−0.58–0.32) 0.034
Snack −0.19 (−0.69–0.25) −0.38 (−0.78–0.09) 0.064 0.09 (−0.37–0.68) 0.10 (−0.35–0.79) 0.365
Modern −0.11 (−0.58–0.42) −0.18 (−0.65–0.19) 0.278 −1.00 (−0.51–0.32) −0.14 (−0.60–0.24) 0.405
Traditional −0.10 (−0.40–0.36) 0.02 (−0.36–0.59) 0.152 −0.22 (−0.67–0.38) −0.24 (−0.62–0.23) 0.809
Fish −0.27 (−0.54–0.68) −0.26 (−0.58–0.68) 0.723 −0.28 (−0.56–0.61) −0.23 (−0.54–0.71) 0.128
High-fat −0.10 (−0.36–0.19) −0.02 (−0.32–0.53) 0.045 −0.28 (−0.52–0.14) −0.22 (−0.49–0.36) 0.257
Data are presented as median (interquartile range). FoH, fear of hypoglycaemia.
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intake has not been extensively studied. What has been previ-
ously observed is that FoH and non-compliance with dietary advices
are unrelated [21], that FoH is not associated with any particular
eating style [22] and the more the individuals were anxious about
hypoglycaemia, the more frequently they ate snacks [11]. Based on
the surprisingly small number of studies conducted in this ﬁeld, it
can be concluded that there is a clear need to more closely study
the association between FoH and dietary intake. Our results re-
garding higher carbohydrate consumption in FoH does, however,
intuitively make sense as higher carbohydrate intake may be used
to keep the blood glucose concentrations elevated. Moreover, the
fact that high fat intake reduces the absorption of carbohydrates,
could explain why FoH was associated with low scores in “high-
fat” factor in men.
Consistent with previous studies, we observed a higher frequen-
cy of FoH among women than men [14,23]. This observation is also
in concordance with what is known about sex difference in anxiety
disorders in the general population [24]. Despite the observed sex
difference in the prevalence of FoH, both men and women with FoH
reported higher SMBG frequency. While SMBG is an important tool
to manage one’s blood glucose, more frequent monitoring in FoH
could indicate the concern related to too low glucose concentra-
tions. However, unlike among men, no difference was observed in
the mean of serial HbA1c measurements in women. Instead women,
regardless of their FoH status, had identical mean serial HbA1c levels
with men with FoH.
Given the high prevalence of FoH and the signiﬁcance of the self-
management practices for the long term complications of diabetes,
the current subject is of major importance. A large number of well
characterised participants provides suﬃcient power to study the de-
scribed associations. There are, however, a number of important
weaknesses that need to be discussed. One major shortcoming is
the use of a non-validated questionnaire to assess FoH. The ques-
tionnaire used was not originally intended for measuring FoH, but
rather for exploring the patients’ subjective perceptions of their
disease. From this questionnaire, we identiﬁed two questions; one
that measures worry (“Are you afraid of hypoglycaemia”), and one
that measures the behavioural aspect of the fear (“Has fear of
hypoglycaemia led you to eat just in case”), as these two sections
are found in a widely used questionnaire [25]. While the validity
of our questionnaire remains unknown, we believe it gives a suf-
ﬁcient approximation of the participants’ subjective perceptions of
their FoH in the real life situation. Importantly, the aim of the current
study was not to assess the frequency of FoH, per se, but rather to
assess how these subjective perceptions are related to various di-
abetes self-management practices and glycaemic control. Another
weakness is the cross-sectional nature of the study that will not
permit causal interpretations of the results. This limitation should
not be of major importance, however, as we did not study the long
term consequences of fear, but rather the current self-management
practices. Whether the cross-sectional nature of the study has con-
sequences for interpreting the HbA1c results, that reﬂect the
glycaemic status over a three-month period, is not known. Third,
the use of a journal to collect data has various limitations. The very
act of reporting self-management practices may lead individuals to
change their habits to reﬂect what is generally thought as advis-
able. Also, underreporting the unhealthy, and over-reporting the
recommended practices may take place. Furthermore, as the journal
was also used to collect data on the SMBG frequency, we cannot
be sure if every measurements conducted were actually reported.
It is likely, however, that the above-mentioned limitations, in the
use of journals, are found in those with and without FoH, alike.
In conclusion FoH, in the current study, was independently as-
sociated with higher frequency of blood glucose monitoring in both
men andwomen. Moreover, in women, FoHwas also associated with
higher energy intake, and in men higher mean of the serial HbA1c
measurements, higher carbohydrate intake, and lower scores in
“high-fat” factor. We observed no association in the level of phys-
ical activity and insulin administration by FoH status. More studies
should be conducted to assess the association between FoH and self-
management practices, and FoH and its long term consequences,
such as the emergence of diabetic complications and mortality.
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